{
    "clinical_study": {
        "@rank": "20305", 
        "arm_group": {
            "arm_group_label": "Treatment (bortezomib)", 
            "arm_group_type": "Experimental", 
            "description": "Patients receive bortezomib IV twice weekly for 2 weeks. Courses repeat every 3 weeks in the absence of disease progression or unacceptable toxicity."
        }, 
        "brief_summary": {
            "textblock": "Phase II trial to study the effectiveness of bortezomib in treating patients who have\n      persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer. Bortezomib\n      may stop the growth of cancer cells by blocking the enzymes necessary for their growth."
        }, 
        "brief_title": "Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 1"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 2"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "26"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "29"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "55"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "11.1", 
                                                "@value": "58.8"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "11.4", 
                                                "@value": "55.8"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "11.2", 
                                                "@value": "57.2"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "20-29 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "30-39 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "10"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "40-49 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "8"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "10"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "18"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "50-59 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "11"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "17"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "60-69 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "5"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "6"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "70-79 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "80-89 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "26"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "29"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "55"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "3"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Canada"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "23"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "29"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "52"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "United States"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Adenocarcinoma, Unspecified"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Endometrioid Adenocarcinoma"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "3"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Mixed Epithelial Carcinoma"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "21"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "25"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "46"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Serous Adenocarcinoma"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Transitional Cell Carcinoma"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Undifferentiated Carcinoma"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Cell Type", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "Cohort 1: 2 participants were not eligible/evaluable after enrollment. Cohort 2: 1 participant was not eligible/evaluable after enrollment."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "26"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "29"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "3.9", 
                                                        "@upper_limit": "3.9", 
                                                        "@value": "3.9"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "2.4", 
                                                        "@upper_limit": "45.9", 
                                                        "@value": "24.1"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Tumor Response Duration", 
                                    "units": "months"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "From study entry, up to 5 years", 
                        "title": "Tumor Response Duration", 
                        "type": "Primary"
                    }, 
                    {
                        "safety_issue": "Yes", 
                        "time_frame": "Up to 5 years", 
                        "title": "Frequency and Severity of Observed Adverse Events", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "26"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "29"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "13.0", 
                                                        "@upper_limit": "29.0", 
                                                        "@value": "18.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "12.7", 
                                                        "@upper_limit": "37.1", 
                                                        "@value": "27.2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Median", 
                                    "title": "Overall Survival", 
                                    "units": "months"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "From study entry, up to 5 years following disease progression", 
                        "title": "Overall Survival", 
                        "type": "Secondary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "26"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "29"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "1.3", 
                                                        "@upper_limit": "4.8", 
                                                        "@value": "1.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "1.4", 
                                                        "@upper_limit": "3.1", 
                                                        "@value": "1.4"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Median", 
                                    "title": "Progression-Free Survival", 
                                    "units": "months"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "From study entry up to 5 years", 
                        "title": "Progression-Free Survival", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Number of participants who experienced an objective tumor response up to 5 years. Per RECIST version 1.0 criteria: each target lesion must be >= 20 mm when measured by conventional techniques, including palpation, plain x-ray, CT, and MRI, or >= 10 mm when measured by spiral CT. Complete Response is a disappearance of all target and non-target lesions. Partial Response is at least a 30% decrease in the sum of longest dimensions (LD) of all target measurable lesions, taking as reference the baseline sum of LD.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 1"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                                    "title": "Cohort 2"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "26"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "29"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.00", 
                                                        "@upper_limit": "0.17", 
                                                        "@value": "1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.01", 
                                                        "@upper_limit": "0.20", 
                                                        "@value": "2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Number of participants who experienced an objective tumor response up to 5 years. Per RECIST version 1.0 criteria: each target lesion must be >= 20 mm when measured by conventional techniques, including palpation, plain x-ray, CT, and MRI, or >= 10 mm when measured by spiral CT. Complete Response is a disappearance of all target and non-target lesions. Partial Response is at least a 30% decrease in the sum of longest dimensions (LD) of all target measurable lesions, taking as reference the baseline sum of LD.", 
                                    "param": "Number", 
                                    "title": "Objective Partial/Complete Tumor Response Based on the Gynecologic Oncology Group (GOG) Response Evaluation Criteria in Solid Tumors (RECIST) Criteria", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "From study entry until disease progression/intolerable toxicity/study withdrawal", 
                        "title": "Objective Partial/Complete Tumor Response Based on the Gynecologic Oncology Group (GOG) Response Evaluation Criteria in Solid Tumors (RECIST) Criteria", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 1"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 2"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Not platinum sensitive"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Never treated"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "total number of participants enrolled on study", 
                                                "@count": "28", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "total number of participants enrolled on study", 
                                                "@count": "30", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "total number of participants eligible and evaluable", 
                                                "@count": "26", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "total number of participants eligible and evaluable", 
                                                "@count": "29", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "recruitment_details": "Accrual was broken down into two cohorts. Cohort 1 enrolled 28 participants from 11/5/2001 through 1/6/2003. Cohort 2 enrolled 30 participants from 4/5/2004 through 9/6/2005."
            }, 
            "point_of_contact": {
                "email": "mleventhal@gogstats.org", 
                "name_or_title": "Melissa Leventhal", 
                "organization": "Gynecologic Oncology Group(GOG) Statistical and Data Center", 
                "phone": "716-845-4030"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Patients enrolled 11/5/2001 through 1/6/2003 receive bortezomib 1.5 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 1"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Patients enrolled 4/5/2004 through 9/6/2005 receive bortezomib 1.3 mg/m2/dose IV twice weekly for 2 weeks (Days 1,4,8, and 11) followed by a 10day rest period (Days 12-21). At least 72 hours should elapse between consecutive doses.Courses repeat every 3 weeks (21 days) until disease progression or adverse effects prohibit further therapy.", 
                            "title": "Cohort 2"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "26", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "29", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Neutropenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "12", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Thrombocytopenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Leukopenia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Transfusion Prbc's"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "17", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Anemia"
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Edema"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Inner Ear/Hearing"
                                    }
                                }, 
                                "title": "Ear and labyrinth disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Ocular Other"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Vision Flashing Lights/Floaters"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Vision Blurres"
                                        }
                                    ]
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Anorexia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Diarrhea Without Colostomy"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Constipation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Stomatitis/Pharyngitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Vomitting"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Gi Other"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Fever(No Neutropenia)"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Weight Gain(No Vod)"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Fatigue"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Abdominal Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Pain Other"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Neuropathic Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Chest Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Bone Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Arthralgia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Myalgia"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Hypoalbuminemia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Sgot(Alt)"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Sgot(Ast)"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Alkaline Phosphatase"
                                        }
                                    ]
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Infection Without Neutropenia"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Metabolic Other"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Hyponatremia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Hypocalcemia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Hyperglycemia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Hypokalemia"
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Confusion"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Mood Alteration Anxiety/Agitation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Insomnia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Dizziness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Mood Alteration Depression"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Neuropathy Sensor"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Creatinine"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Urinary Retention"
                                        }
                                    ]
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Cough"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Pneumonitis/Pulmonary Infiltrates"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Dyspnea"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Alopecia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Rash Desquamation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Urticaria"
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_vocab": "CTCAE (2.0)", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Anemia"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Caridic Left Ventricular Function"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Ileus"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Diarrhea Without Colostomy"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Constipation"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Gi Other"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Neuropathic Pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "26"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "29"
                                                }
                                            ], 
                                            "sub_title": "Myalgia"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Sgot(Ast)"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Cns Cerebrovascular Ischemia"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "26"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "29"
                                            }
                                        ], 
                                        "sub_title": "Dyspnea"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_vocab": "CTCAE (2.0)"
                }, 
                "time_frame": "All Adverse Events(AEs) occurring during treatment and up to 30 days after stopping the study treatment are reported. Also reported are Serious Adverse Events (SAEs) considered to be treatment related for up to 5 years after stopping study treatment."
            }
        }, 
        "completion_date": {
            "#text": "January 2010", 
            "@type": "Actual"
        }, 
        "condition": [
            "Primary Peritoneal Cavity Cancer", 
            "Recurrent Ovarian Epithelial Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Peritoneal Neoplasms", 
                "Neoplasms, Glandular and Epithelial", 
                "Ovarian Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. Determine the antitumor activity of bortezomib in patients with persistent or recurrent\n      platinum-sensitive ovarian epithelial or primary peritoneal carcinoma.\n\n      II. Determine the nature and degree of toxicity of this regimen in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive bortezomib IV twice weekly for 2 weeks. Courses repeat every 3 weeks in the\n      absence of disease progression or unacceptable toxicity.\n\n      Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then\n      annually thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed persistent or recurrent ovarian epithelial or primary\n             peritoneal carcinoma\n\n          -  Measurable disease\n\n               -  At least 20 mm by conventional techniques (e.g., palpation, x-ray, plain CT\n                  scan, or MRI) OR at least 10 mm by spiral CT scan\n\n          -  Must have had prior therapy with no more than 1 platinum-based chemotherapy regimen\n             for primary disease (e.g., carboplatin, cisplatin, or other organoplatinum compound)\n\n               -  A second regimen containing paclitaxel allowed provided patient received no\n                  prior paclitaxel therapy\n\n          -  Platinum-sensitive disease\n\n               -  Treatment-free interval without progressive disease for more than 6 months but\n                  less than 12 months after therapy with platinum-based regimen\n\n          -  At least 1 target lesion outside previously irradiated field\n\n          -  Ineligible for higher priority GOG protocol\n\n          -  Performance status - GOG 0-2 (if received 1 prior therapy regimen)\n\n          -  Performance status - GOG 0-1 (if received 2 prior therapy regimens)\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n          -  Bilirubin no greater than 1.5 times upper limit of normal (ULN)\n\n          -  SGOT no greater than 2.5 times ULN\n\n          -  Alkaline phosphatase no greater than 2.5 times ULN\n\n          -  Creatinine no greater than 1.5 times ULN\n\n          -  No evidence of acute ischemia or significant conduction abnormality (e.g., left\n             anterior hemiblock in the presence of right bundle branch block or second or third\n             degree atrioventricular block) on electrocardiogram\n\n          -  No myocardial infarction within the past 6 months\n\n          -  No cerebrovascular event or transient ischemic attack within the past 6 months\n\n          -  Not pregnant or nursing\n\n          -  Negative pregnancy test\n\n          -  Fertile patients must use effective contraception\n\n          -  No active infection requiring antibiotics\n\n          -  No other invasive malignancy within the past 5 years except non-melanoma skin cancer\n\n          -  No sensory or motor neuropathy greater than grade 1\n\n          -  No more than 1 prior non-cytotoxic regimen (e.g., monoclonal antibodies, cytokines,\n             or small-molecule inhibitors of signal transduction) for recurrent or persistent\n             disease\n\n          -  At least 4 weeks since prior biological or immunological agents and recovered\n\n          -  No prior cytotoxic chemotherapy for recurrent or persistent disease, including\n             retreatment with initial chemotherapy regimen\n\n          -  At least 4 weeks since prior chemotherapy and recovered\n\n          -  At least 1 week since prior anti-cancer hormonal therapy and recovered\n\n          -  Concurrent hormone replacement therapy allowed\n\n          -  At least 4 weeks since prior radiotherapy and recovered\n\n          -  No prior radiotherapy to target lesions\n\n          -  No prior radiotherapy to more than 25% of marrow-bearing areas\n\n          -  At least 4 weeks since prior surgery and recovered\n\n          -  No prior bortezomib\n\n          -  No prior anti-cancer therapy that would preclude study treatment\n\n          -  No concurrent amifostine or other protective agents"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "58", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 13, 2001", 
        "firstreceived_results_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00023712", 
            "org_study_id": "NCI-2012-02404", 
            "secondary_id": [
                "NCI-2012-02404", 
                "CDR0000068853", 
                "GOG-0146N", 
                "GOG #0146N", 
                "GOG-0146N", 
                "U10CA027469"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Treatment (bortezomib)", 
                "description": "Given IV", 
                "intervention_name": "bortezomib", 
                "intervention_type": "Drug", 
                "other_name": [
                    "LDP 341", 
                    "MLN341", 
                    "VELCADE"
                ]
            }, 
            {
                "arm_group_label": "Treatment (bortezomib)", 
                "description": "Correlative studies", 
                "intervention_name": "laboratory biomarker analysis", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Treatment (bortezomib)", 
                "description": "Correlative studies", 
                "intervention_name": "pharmacological study", 
                "intervention_type": "Other", 
                "other_name": "pharmacological studies"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Bortezomib"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19103"
                }, 
                "name": "Gynecologic Oncology Group"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase II Evaluation of Bortezomib (Velcade\u2122, PS-341, NSC #681239, IND #58443) in the Treatment of Persistent or Recurrent Platinum-Sensitive Epithelial Ovarian or Primary Peritoneal Cancer", 
        "overall_official": {
            "affiliation": "Gynecologic Oncology Group", 
            "last_name": "Carol Aghajanian", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Tumor Response Duration", 
                "safety_issue": "No", 
                "time_frame": "From study entry, up to 5 years"
            }, 
            {
                "measure": "Frequency and Severity of Observed Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 5 years"
            }, 
            {
                "description": "Number of participants who experienced an objective tumor response up to 5 years. Per RECIST version 1.0 criteria: each target lesion must be >= 20 mm when measured by conventional techniques, including palpation, plain x-ray, CT, and MRI, or >= 10 mm when measured by spiral CT. Complete Response is a disappearance of all target and non-target lesions. Partial Response is at least a 30% decrease in the sum of longest dimensions (LD) of all target measurable lesions, taking as reference the baseline sum of LD.", 
                "measure": "Objective Partial/Complete Tumor Response Based on the Gynecologic Oncology Group (GOG) Response Evaluation Criteria in Solid Tumors (RECIST) Criteria", 
                "safety_issue": "No", 
                "time_frame": "From study entry until disease progression/intolerable toxicity/study withdrawal"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00023712"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Overall Survival", 
                "safety_issue": "No", 
                "time_frame": "From study entry, up to 5 years following disease progression"
            }, 
            {
                "measure": "Progression-Free Survival", 
                "safety_issue": "No", 
                "time_frame": "From study entry up to 5 years"
            }
        ], 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 2004", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }, 
    "geocoordinates": {
        "Gynecologic Oncology Group": "39.952 -75.164"
    }
}